Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Ad5-survivin-transduced autologous DC vaccine|
Ad5-survivin-transduced autologous DC vaccine consists of autologous dendritic cells engineered to carry a replication defective adenovirus type 5 vector (Ad5) that encodes a survivin antigen, which potentially activates a cytotoxic T-lymphocyte response against survivin-expressing tumor cells, resulting in cell death (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Ad5-survivin-transduced autologous DC vaccine||Ad5-survivin-transduced autologous DC vaccine||0||0|
|Ad5-survivin-transduced autologous DC vaccine + Filgrastim + PCV13 vaccine||Ad5-survivin-transduced autologous DC vaccine Filgrastim PCV13 vaccine||0||1|